IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.100
+0.010 (0.92%)
Sep 2, 2026, 1:49 PM EDT - Market open
IN8bio Market Cap
IN8bio has a market cap or net worth of $10.84 million as of September 2, 2026. Its market cap has increased by 8.09% in one year.
Market Cap
10.84M
Enterprise Value
-4.93M
1-Year Change
8.09%
Ranking
Category
Stock Price
$1.10
ChartMarket Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $10.84M, a decrease of -94.22%. That is a compound annual growth rate of -42.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 10.84M | -52.52% |
| Dec 31, 2025 | 22.84M | 22.52% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 11.43M |
| PDS Biotechnology | 11.42M |
| MetaVia | 11.33M |
| Kiora Pharmaceuticals | 11.11M |
| Vistagen Therapeutics | 10.80M |
| Azitra | 10.71M |
| Senti Biosciences Holdings | 10.59M |
| CytoMed Therapeutics | 10.56M |